Table 1 Baseline clinical characteristics
|  | Total population (n=55) | IDE (n = 38) | CDE (n = 17) | P value |
|---|---|---|---|---|
Age (years) | 70.71 ± 8.04 | 72.21 ± 8.141 | 69.56 ± 7.938 | 0.492 |
Male gender, n (%) | 29 (52.7) | 19 (50.0) | 10 (58.8) | 0.545 |
BMI (kg/m2) | 25.97 ± 3.74 | 25.12 ± 3.17 | 27.85 ± 4.32 | 0.028 |
Hypertension, n (%) | 44 (80.0) | 31 (81.6) | 13 (76.5) | 0.662 |
Stroke, n (%), n (%) | 23 (41.8) | 16 (42.1) | 7 (41.2) | 0.949 |
Diabetes, n (%) | 14 (25.5) | 11 (28.9) | 3 (17.6) | 0.374 |
Coronary heart disease, n (%) | 20 (36.4) | 12 (31.6) | 8 (47.1) | 0.270 |
Persistent/permanent AF, n (%) | 32 (58.2) | 20 (52.6) | 12 (70.6) | 0.212 |
CHA2DS2-VASc score | 4.45 ± 1.71 | 4.55 ± 1.639 | 4.24 ± 1.888 | 0.554 |
HAS-BLED score | 2.67 ± 0.94 | 2.68 ± 0.933 | 2.65 ± 0.996 | 0.894 |
TTE measurement | Â | Â | Â | Â |
 LA (mm) | 44.65 ± 6.28 | 44.68 ± 4.662 | 44.59 ± 9.111 | 0.968 |
 LVEF (%) | 61.18 ± 6.79 | 60.74 ± 7.325 | 62.18 ± 5.457 | 0.423 |
 LVEDD (mm) | 47.35 ± 5.32 | 47.26 ± 5.51 | 47.53 ± 5.04 | 0.861 |
 LVESD (mm) | 31.45 ± 5.07 | 31.61 ± 5.38 | 31.12 ± 4.44 | 0.727 |
Procedural characteristics of LAAC | Â | Â | Â | Â |
 Device size (mm) | 26.82 ± 3.4 | 26.61 ± 3.33 | 27.29 ± 3.62 | 0.509 |
 Device compression ratio (%) | 21.62 ± 4.68 | 21.66 ± 4.46 | 21.54 ± 5.40 | 0.945 |
 Peri-device leak (mm) | 0.03 ± 0.23 | 0.04 ± 0.28 | 0.00 ± 0.00 | 0.324 |
Warfarin at discharge | 19 (34.5) | 13 (34.2) | 6 (35.3) | 0.938 |